JOAQUÍN
DÍAZ MEDIAVILLA

Researcher to 2014

Foto de JOAQUÍN

Foto de Hospital Universitario de Canarias

Hospital Universitario de Canarias

San Cristóbal de La Laguna, España

Publications in collaboration with researchers from Hospital Universitario de Canarias (5)

2012

Benefit from autologous stem cell transplantation in primary refractory myeloma? Different outcomes in progressive versus stable disease
Haematologica, Vol. 97, Núm. 4, pp. 616-621
High-risk cytogenetics and persistent minimal residual disease by multiparameter flow cytometry predict unsustained complete response after autologous stem cell transplantation in multiple myeloma
Blood, Vol. 119, Núm. 3, pp. 687-691
Superiority of bortezomib, thalidomide, and dexamethasone (VTD) as induction pretransplantation therapy in multiple myeloma: A randomized phase 3 PETHEMA/GEM study
Blood, Vol. 120, Núm. 8, pp. 1589-1596

2010

Busulfan 12 mg/kg plus melphalan 140 mg/m2 versus melphalan 200 mg/m2 as conditioning regimens for autologous transplantation in newly diagnosed multiple myeloma patients included in the PETHEMA/GEM2000 study
Haematologica, Vol. 95, Núm. 11, pp. 1913-1920

2008

A prospective PETHEMA study of tandem autologous transplantation versus autograft followed by reduced-intensity conditioning allogeneic transplantation in newly diagnosed multiple myeloma
Blood, Vol. 112, Núm. 9, pp. 3591-3593